Inhibrx Biosciences Inc (INBX)
R&D Expense Growth
-44.52%
Fiscal year · Period ending:
INBX R&D Expense Growth
Latest reported-44.52%period ending
Latest reported-44.52%period ending
INBX FY R&D Growth (YoY) (0.00% → -44.52%)
Latest values, visible window
High-resolution chart · PNG
INBX r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -44.5242% | |
| 6.8687% | |
| 73.0238% | |
| 54.2357% | |
| -2.7961% | |
| 53.4118% | |
| 43.2026% | |
| 31.1407% | |
| 50.1295% | |
| 0% |